Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, Ligresti A, Presta M, Ronca R. Chiodelli P, et al. Among authors: turati m. Cancer Lett. 2022 Feb 1;526:217-224. doi: 10.1016/j.canlet.2021.11.030. Epub 2021 Dec 1. Cancer Lett. 2022. PMID: 34861311
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.
Matarazzo S, Melocchi L, Rezzola S, Grillo E, Maccarinelli F, Giacomini A, Turati M, Taranto S, Zammataro L, Cerasuolo M, Bugatti M, Vermi W, Presta M, Ronca R. Matarazzo S, et al. Among authors: turati m. Cancers (Basel). 2019 Aug 30;11(9):1277. doi: 10.3390/cancers11091277. Cancers (Basel). 2019. PMID: 31480336 Free PMC article.
Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells.
Liguori F, Carradori S, Ronca R, Rezzola S, Filiberti S, Carta F, Turati M, Supuran CT. Liguori F, et al. Among authors: turati m. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1857-1869. doi: 10.1080/14756366.2022.2091557. J Enzyme Inhib Med Chem. 2022. PMID: 35768159 Free PMC article.
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer.
Maccarinelli F, Coltrini D, Mussi S, Bugatti M, Turati M, Chiodelli P, Giacomini A, De Cillis F, Cattane N, Cattaneo A, Ligresti A, Asperti M, Poli M, Vermi W, Presta M, Ronca R. Maccarinelli F, et al. Among authors: turati m. Cell Death Discov. 2023 Mar 6;9(1):81. doi: 10.1038/s41420-023-01383-4. Cell Death Discov. 2023. PMID: 36872341 Free PMC article.
TGF-β mediated drug resistance in solid cancer.
Turati M, Mousset A, Issa N, Turtoi A, Ronca R. Turati M, et al. Cytokine Growth Factor Rev. 2023 Jun-Aug;71-72:54-65. doi: 10.1016/j.cytogfr.2023.04.001. Epub 2023 Apr 11. Cytokine Growth Factor Rev. 2023. PMID: 37100675 Review.
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer.
Giacomini A, Turati M, Grillo E, Rezzola S, Ghedini GC, Schuind AC, Foglio E, Maccarinelli F, Faletti J, Filiberti S, Chambery A, Valletta M, Melocchi L, Gofflot S, Chiavarina B, Turtoi A, Presta M, Ronca R. Giacomini A, et al. Among authors: turati m. Exp Hematol Oncol. 2023 Sep 25;12(1):82. doi: 10.1186/s40164-023-00441-y. Exp Hematol Oncol. 2023. PMID: 37749607 Free PMC article.
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells.
Masci D, Puxeddu M, Di Magno L, D'Ambrosio M, Parisi A, Nalli M, Bai R, Coluccia A, Sciò P, Orlando V, D'Angelo S, Biagioni S, Urbani A, Hamel E, Nocentini A, Filiberti S, Turati M, Ronca R, Kopecka J, Riganti C, Fionda C, Bordone R, Della Rocca G, Canettieri G, Supuran CT, Silvestri R, La Regina G. Masci D, et al. Among authors: turati m. J Med Chem. 2023 Nov 9;66(21):14824-14842. doi: 10.1021/acs.jmedchem.3c01424. Epub 2023 Oct 30. J Med Chem. 2023. PMID: 37902628 Free PMC article.
72 results